Dental Care Clinics in Roselle, NJ Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Tender Smiles Of Roselle Pa Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 2209 Wood Ave, Roselle, NJ 07203 Phone: 908-245-5556 |
Children's Dental Health Associates Of Roselle P.c. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 2209 Wood Ave, Roselle, NJ 07203 Phone: 908-245-5556 |
Roselle Commons Dental Center, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 711 E 1st Ave Ste 5, Roselle, NJ 07203 Phone: 908-259-0505 Fax: 908-259-9885 |
Center For Oral Surgery & Dental Implants Of Roselle Llc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 2305 Wood Ave, Roselle, NJ 07203 Phone: 908-241-2114 |
E Gerald Coopersmith Dmd Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 2305 N. Wood Ave, Roselle, NJ 07203 Phone: 908-241-2114 Fax: 908-241-6001 |
Rj Dental, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 121 - 125 Chestnut St., Ste. 201, Roselle, NJ 07203 Phone: 908-241-6455 Fax: 908-241-6367 |
News Archive
FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
Medicare for all? CMS chief warns program has enough problems already
The Trump administration's top Medicare official Tuesday slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.
Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
'Blue baby' study sheds light on basic biology
A newborn described as a "happy blue baby" because of her bluish skin color but healthy appearance made a small mark in medical history when one of her physicians discovered something new in her genes-the hemoglobin Toms River mutation.
› Verified 4 days ago